[1] 杨军,王静,刘信顺,等.博落回的药效研究[J].中药材,1999,22(2):82-5.Yang J,Wang J. Experimental studies on pharmacodynamic effect of Macleaya. cordata[J]. J Chin Med Mat,1999,22(2):82-5. [2] Chmura SJ,Dolan ME,Cha A,et al. In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo [J]. Clin Cancer Res,2000,6(2):737-42. [3] Hoffmann TK,Leenen K,Hafner D,et al. Antitumor activity of protein kinase C inhibitors and cisplatin in human head and neck squamous cell carcinoma lines [J]. Anticancer Drugs,2002,13(1):93-100. [4] 袁涛忠,张华生.博落回杀灭蝇蛆效果的实验观察[J].寄生虫及寄生虫病学杂志,1999,21:128. [5] 樊淑莲,焦峰,张园,等.博落回总生物碱对动物移植性肿瘤的作用研究[J].陕西肿瘤医学,2000,8(3):174-9. [6] 吴茂旺,朱建华.博落回药理研究与应用概况[J].基层中药杂志2002,16(3):46-8. [7] 任新玲,沈丽英,金伯泉,等.表皮生长因子受体单克隆抗体抗肺癌作用的研究[J].肿瘤,2000,20(1):35-7.Ren XL,Shen Ly,Jin BQ,et al. Efficacy of epidermal growth factor receptor antibody against lung cancer in vitro and in nude mice [J].Tumor,2000,20(1):35-7. [8] 徐淑云,卞如濂,陈修.药理实验方法学[M].人民卫生出版社,1991.1428. [9] 李仪奎.中药药理实验方法学[M].上海科学技术出版社,1991.513. [10] 彭海鹏.博落回的开发利用[J].中国野生植物资源(Chin Wild Plant Resour),2003,22(3):58. [11] Herbert JM,Augereau JM,Gleye J,et al. Chelerythrine is a potent and specific inhibitor of protein kinase C [J]. Biochem Biophys Res Commun,1990,172(3):993-9. [12] Olivero P,Stutzin A. Calcium modulates osmosensitive taurine efflux in HeLa cells[J]. Neurochem Res,2004,29(1):169-76. [13] Kim J,Lin J,Adam RM,et al. An oxidative stress mechanism mediates chelerythrine-induced heparin-binding EGF-like growth factor ectodomain shedding [J]. J Cell B iochem,2004,15 [Epub ahead of print]. [14] Faddeeva MD,Beliaeva TN. Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action [J]. Tsitologiia,1997,39(2-3):181-208. |